These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 610543)

  • 21. [Thyroglobulin: usefulness and limits in monitoring patients with thyroid carcinoma].
    Hammami H; Sellem A; Ben Sellem D; Aouni Z; Elabri SB; Mezigh C; Machghoul S; Ben Brahim H
    Tunis Med; 2007 Feb; 85(2):128-30. PubMed ID: 17665659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of the assay of thyroglobulin for postoperative surveillance of differentiated thyroid cancers].
    Jaffiol C; Baldet L
    Ann Med Interne (Paris); 1984; 135(5):359-64. PubMed ID: 6486615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma.
    Rüter A; Smeds S; Lennquist S
    Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum thyroglobulin in thyroid cancer and other thyroid diseases].
    Demidchik EP; Kruglova NE; Minaĭlo TI; Gauptman AE; Koren' TA; Gedrevich ZE; Sevkovskiĭ IaI
    Lab Delo; 1990; (7):16-8. PubMed ID: 1699058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical utility of Lens culinaris agglutinin-reactive thyroglobulin ratio in serum for distinguishing benign from malignant conditions of the thyroid.
    Shimizu K; Nakamura K; Kobatake S; Satomura S; Maruyama M; Kameko F; Tajiri J; Kato R
    Clin Chim Acta; 2007 Apr; 379(1-2):101-4. PubMed ID: 17270168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma.
    Sawka AM; Orlov S; Gelberg J; Stork B; Dowar M; Shaytzag M; Tabatabaie V; Freeman JL; Walfish PG
    Head Neck; 2008 Jun; 30(6):693-700. PubMed ID: 18098308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of thyroglobulin (TGL) assay in following the post-therapeutic course of differentiated thyroid cancer.
    Socolov C; Pop A; Simionescu L
    Endocrinologie; 1986; 24(1):39-43. PubMed ID: 3961413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Usefulness and limitations of thyroglobulin determination in thyroid neoplasms].
    Dussault J
    Union Med Can; 1983 Dec; 112(12):1119-20, 1123. PubMed ID: 6665951
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum thyroglobulin in thyroid neoplasms].
    Mimura T; Ishikawa N; Hasegawa M; Manabe Y; Momotani S
    Horumon To Rinsho; 1983 Aug; 31(8):731-5. PubMed ID: 6627707
    [No Abstract]   [Full Text] [Related]  

  • 32. Ambiguous thyroglobulin assay results in the follow-up of differentiated thyroid carcinoma.
    Stockigt JR
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5904-5. PubMed ID: 16207895
    [No Abstract]   [Full Text] [Related]  

  • 33. Caveat in the use of serum thyroglobulin determinations for monitoring differentiated thyroid carcinoma.
    Schwartz MA
    Clin Chem; 1980 May; 26(6):794. PubMed ID: 7371174
    [No Abstract]   [Full Text] [Related]  

  • 34. Analytical validation of two second generation thyroglobulin immunoassays (Roche and Thermo Fisher).
    Moussallieh FM; Ranaivosoa MK; Romain S; Reix N
    Clin Chem Lab Med; 2018 Nov; 56(12):e302-e305. PubMed ID: 29927744
    [No Abstract]   [Full Text] [Related]  

  • 35. [In search of the ideal essay for blood thyroglobulin determination in the followup of patients with differentiated thyroid cancer].
    Maciel RM
    Arq Bras Endocrinol Metabol; 2004 Aug; 48(4):434-6. PubMed ID: 15761504
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of subsequent pregnancy on patients with thyroid carcinoma apparently free of the disease.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Nov; 17(11):1175-6. PubMed ID: 18047435
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum "thyroglobulin" in thyroidal carcinoma.
    OWEN CA; McCONAHEY WM; CHILDS DS; McKENZIE BF
    J Clin Endocrinol Metab; 1960 Feb; 20():187-204. PubMed ID: 14429540
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemiluminescent assay for serum thyroglobulin in the management of patients with thyroid carcinoma.
    Perry LA; Dawnay A
    Clin Chem; 2001 Apr; 47(4):778-9. PubMed ID: 11274041
    [No Abstract]   [Full Text] [Related]  

  • 39. The evolution of positron emission tomography.
    Ho GC
    Singapore Med J; 2005 Jun; 46(6):257-8. PubMed ID: 15902352
    [No Abstract]   [Full Text] [Related]  

  • 40. Changes in plasma thyroglobulin levels in experimentally aged blood.
    Katsumata Y; Sato K; Kido A; Oya M; Yada S; Suzuki O
    J Forensic Sci Soc; 1983 Apr; 23(2):143-6. PubMed ID: 6875505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.